Hot Pursuit     20-Jun-14
Orchid Chemicals jumps on USFDA nod for a medicine
Orchid Chemicals & Pharmaceuticals surged 6.12% to Rs 76.25 at 9:17 IST on BSE after the company said it has received approval from USFDA for its abbreviated new drug application for Eszopiclone tablets, 1 mg, 2 mg, and 3 mg strengths.

The announcement was made after market hours on Thursday, 19 June 2014.

Meanwhile, the S&P BSE Sensex was up 26.65 points or 0.11% at 25,228.45.

On BSE, so far 1.47 lakh shares were traded in the counter as against average daily volume of 7.97 lakh shares in the past two weeks.

The stock hit a high of Rs 76.80 and a low of Rs 75.10 so far during the day.

Orchid Chemicals & Pharmaceuticals reported a net loss of Rs 80.79 crore in the quarter ended 31 March 2014, lower than net loss of Rs 132.27 crore in the quarter ended 31 March 2013. Net sales rose 67.2% to Rs 448.46 crore in the quarter ended 31 March 2014 over the quarter ended 31 March 2013.

Orchid Chemicals & Pharmaceuticals is involved in the development, manufacture and marketing of diverse bulk activities, formulations and nutraceuticals.

Previous News
  Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter
 ( Results - Announcements 13-Aug-24   07:29 )
  Orchid Pharma announces board meeting date
 ( Corporate News - 10-Aug-24   12:49 )
  Orchid Pharma to conduct AGM
 ( Corporate News - 18-Jul-24   20:35 )
  Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
 ( Hot Pursuit - 29-Jun-24   10:08 )
  Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
 ( Corporate News - 28-Jun-24   19:23 )
  Sensex up 273 pts; IT shares outperforms
 ( Market Commentary - Mid-Session 06-Jun-24   14:42 )
  Orchid Pharma receives DCGI approval for Enmetazobactam
 ( Corporate News - 06-Jun-24   13:06 )
  Orchid Pharma gains on DCGI nod for new antibiotic drug combination
 ( Hot Pursuit - 06-Jun-24   12:38 )
  Orchid Pharma slides as PAT slumps 49% YoY in Q4 FY24
 ( Hot Pursuit - 24-May-24   12:56 )
  Orchid Pharma consolidated net profit declines 44.27% in the March 2024 quarter
 ( Results - Announcements 24-May-24   07:34 )
  Orchid Pharma to conduct board meeting
 ( Corporate News - 17-May-24   14:12 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top